Quick Answer
Twist Bioscience Corp reported Earnings Per Share Diluted of $1.30 (loss) per share for the year ending 2025.
- Twist Bioscience Corp showed an increase of +63.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Twist Bioscience Corp's annual report (Form 10-K), filed with the SEC on November 17, 2025.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $0.78 (loss) per share | Q2 2021: $0.82 (loss) per share | Q4 2021: $0.91 (loss) per share | Q1 2022: $1.13 (loss) per share | Q2 2022: $1.08 (loss) per share | Q4 2022: $0.74 (loss) per share | Q1 2023: $1.04 (loss) per share | Q2 2023: $1.01 (loss) per share | Q4 2023: $0.75 (loss) per share | Q1 2024: $0.79 (loss) per share | Q2 2024: $1.47 (loss) per share | Q4 2024: $0.53 (loss) per share | Q1 2025: $0.66 (loss) per share | Q2 2025: $0.33 per share | Q4 2025: $0.50 (loss) per share.
- Over the full 6 years of available data (2020 to 2025), Twist Bioscience Corp's Earnings Per Share Diluted has grown by 63.6%.
- Historical annual values: Fiscal year 2025: $1.30 (loss) per share | Fiscal year 2024: $3.60 (loss) per share | Fiscal year 2023: $3.60 (loss) per share | Fiscal year 2022: $4.04 (loss) per share | Fiscal year 2021: $3.15 (loss) per share | Fiscal year 2020: $3.57 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: